Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  169 results for ""Lung Neoplasms""

Your Filters

Content Provider : MEDLINE Publication : international journal of oncology Format : Academic Journals Format : Reviews Subject : carcinoma, non-small-cell lung
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Targeting the Hippo pathway to prevent radioresistance brain metastases from the lung (Review).

  • Authors : Taylor J; University of Caen Normandy, National Center for Scientific Research, Normandy University, Unit of Imaging and Therapeutic Strategies for Cancers and Cerebral Tissues (ISTCT)‑UMR6030, GIP CYCERON, F‑14074 Caen, France.; Dubois F

Subjects: Brain Neoplasms*/Brain Neoplasms*/Brain Neoplasms*/secondary ; Brain Neoplasms*/Brain Neoplasms*/Brain Neoplasms*/radiotherapy ; Brain Neoplasms*/Brain Neoplasms*/Brain Neoplasms*/metabolism

  • Source: International journal of oncology [Int J Oncol] 2024 Jul; Vol. 65 (1). Date of Electronic Publication: 2024 May 24.Publisher: D.A. Spandidos Country of Publication: Greece NLM ID: 9306042 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Polydatin, a potential NOX5 agonist, synergistically enhances antitumor activity of cisplatin by stimulating oxidative stress in non‑small cell lung cancer.

  • Authors : Wu S; Cellular and Molecular Biology Laboratory, Affiliated Zhoushan Hospital of Wenzhou Medical University, Zhoushan, Zhejiang 316020, P.R. China.; Zhao Q

Subjects: Cisplatin*/Cisplatin*/Cisplatin*/pharmacology ; Cisplatin*/Cisplatin*/Cisplatin*/therapeutic use ; Glucosides*/Glucosides*/Glucosides*/pharmacology

  • Source: International journal of oncology [Int J Oncol] 2024 Aug; Vol. 65 (2). Date of Electronic Publication: 2024 Jun 14.Publisher: D.A. Spandidos Country of Publication: Greece NLM ID: 9306042 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

SLCO4A1, as a novel prognostic biomarker of non‑small cell lung cancer, promotes cell proliferation and migration.

  • Authors : Li S; Department of Thoracic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, P.R. China.; Li Z

Subjects: Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/pathology ; Lung Neoplasms*/Lung Neoplasms*/Lung Neoplasms*/pathology ; MicroRNAs*/MicroRNAs*/MicroRNAs*/metabolism

  • Source: International journal of oncology [Int J Oncol] 2024 Mar; Vol. 64 (3). Date of Electronic Publication: 2024 Jan 26.Publisher: D.A. Spandidos Country of Publication: Greece NLM ID: 9306042 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

The emerging roles of CEACAM6 in human cancer (Review).

  • Authors : Wu G; Department of Biliary‑Pancreatic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430074, P.R. China.; Wang D

Subjects: Adenocarcinoma*/Adenocarcinoma*/Adenocarcinoma*/genetics ; Carcinoma, Non-Small-Cell Lung* ; Pancreatic Neoplasms*/Pancreatic Neoplasms*/Pancreatic Neoplasms*/pathology

  • Source: International journal of oncology [Int J Oncol] 2024 Mar; Vol. 64 (3). Date of Electronic Publication: 2024 Jan 19.Publisher: D.A. Spandidos Country of Publication: Greece NLM ID: 9306042 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Anti‑PD‑1/PD‑L1 and anti‑CTLA‑4 associated checkpoint inhibitor pneumonitis in non‑small cell lung cancer: Occurrence, pathogenesis and risk factors (Review).

  • Authors : Hu X; Department of Respiratory and Critical Care Medicine, The Second Hospital of Jilin University, Changchun, Jilin 130041, P.R. China.; Ren J

Subjects: Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/drug therapy ; Lung Neoplasms*/Lung Neoplasms*/Lung Neoplasms*/drug therapy ; Pneumonia*

  • Source: International journal of oncology [Int J Oncol] 2023 Nov; Vol. 63 (5). Date of Electronic Publication: 2023 Sep 08.Publisher: D.A. Spandidos Country of Publication: Greece NLM ID: 9306042 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Cyclovirobuxine D inhibits growth and progression of non‑small cell lung cancer cells by suppressing the KIF11‑CDC25C‑CDK1‑CyclinB1 G 2 /M phase transition regulatory network and the NFκB/JNK signaling pathway.

  • Authors : Xue T; State Key Laboratory for Pneumoconiosis of National Health Commission, Key Laboratory of Prevention, Treatment and Fundamental Studies for Respiratory Diseases of Shanxi, Department of Respiratory and Critical Care Medicine, First Hospital of Shanxi Medical University, Taiyuan, Shanxi 030001, P.R. China.; Chen Y

Subjects: Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/drug therapy ; Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/genetics ; Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/metabolism

  • Source: International journal of oncology [Int J Oncol] 2023 May; Vol. 62 (5). Date of Electronic Publication: 2023 Mar 17.Publisher: D.A. Spandidos Country of Publication: Greece NLM ID: 9306042 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Dual inhibition of EGFR‑VEGF: An effective approach to the treatment of advanced non‑small cell lung cancer with EGFR mutation (Review).

  • Authors : Wang Q; School of Medical and Life Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan 611137, P.R. China.; Zeng A

Subjects: Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/drug therapy ; Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/genetics ; Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/pathology

  • Source: International journal of oncology [Int J Oncol] 2023 Feb; Vol. 62 (2). Date of Electronic Publication: 2023 Jan 05.Publisher: D.A. Spandidos Country of Publication: Greece NLM ID: 9306042 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Targeting the STAT5A/IDO1 axis overcomes radioresistance and reverses the immunosuppressive tumor microenvironment in NSCLC.

  • Authors : Yang Y; Department of Radiation Oncology, The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, Henan 450008, P.R. China.; Zheng X

Subjects: Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/genetics ; Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/radiotherapy ; Lung Neoplasms*/Lung Neoplasms*/Lung Neoplasms*/genetics

  • Source: International journal of oncology [Int J Oncol] 2023 Jan; Vol. 62 (1). Date of Electronic Publication: 2022 Dec 01.Publisher: D.A. Spandidos Country of Publication: Greece NLM ID: 9306042 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Gefitinib enhances the anti‑tumor immune response against EGFR‑mutated NSCLC by upregulating B7H5 expression and activating T cells via CD28H.

  • Authors : Guo H; Zhejiang Provincial Key Laboratory of Media Biology and Pathogenic Control, Central Laboratory, The First Affiliated Hospital of Huzhou University, Huzhou, Zhejiang 313000, P.R. China.; Zhang X

Subjects: Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/pharmacology ; Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/drug therapy ; Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/genetics

  • Source: International journal of oncology [Int J Oncol] 2022 Dec; Vol. 61 (6). Date of Electronic Publication: 2022 Oct 07.Publisher: D.A. Spandidos Country of Publication: Greece NLM ID: 9306042 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Recent advances in postoperative pulmonary rehabilitation of patients with non‑small cell lung cancer (Review).

  • Authors : Su XE; Department of Anaesthesia, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian 362000, P.R. China.; Hong WP

Subjects: Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/pathology ; Lung Neoplasms*/Lung Neoplasms*/Lung Neoplasms*/pathology; Humans

  • Source: International journal of oncology [Int J Oncol] 2022 Dec; Vol. 61 (6). Date of Electronic Publication: 2022 Nov 02.Publisher: D.A. Spandidos Country of Publication: Greece NLM ID: 9306042 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
  • 1-10 of  169 results for ""Lung Neoplasms""